Skip to content

Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI

Diagnostik Und Evaluierung Hepato-pankreatiko-biliärer Erkrankungen Mittels Morphologischer Und Funktioneller Magnetresonanztomographie

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04701567
Enrollment
2000
Registered
2021-01-08
Start date
2020-06-30
Completion date
2023-12-30
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Pancreas Disease

Brief summary

This is a retrospective review of images from patient data. There is no recruitment necessary for this study. Research Question: Can advanced multiparametric MRI techniques improve the detection and characterization of focal and diffuse liver disease, accurately assess treatment response and predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced multiparametric MRI techniques improve the detection, characterization and response assessment of focal and diffuse liver disease and can predict serious liver related outcomes.

Interventions

DIAGNOSTIC_TESTMagnetic resonance imaging

Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen. * 18 years of age and older.

Exclusion criteria

* Age less than 18 years. * Lack of MRI of the abdomen. * Inadequate image quality. * Documented rejection to participate in research studies

Design outcomes

Primary

MeasureTime frameDescription
Pathology findings in focal and/or diffuse liver disease1 yearPathology findings in focal and/or diffuse liver disease
Pathology findings in focal and/or diffuse pancreatic disease1 yearPathology findings in focal and/or diffuse pancreatic disease

Countries

Switzerland

Contacts

Primary ContactCaecilia Reiner, MD
caecilia.reiner@usz.ch+41442551111
Backup ContactReiner
caecilia.reiner@usz.ch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026